Reverse Transcriptase(逆转录酶)

Cat.No. 产品名称 Information

GC25867 Rilpivirine Hydrochloride Rilpivirine (TMC278), is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.

GC65207 R-10015 R-10015 is a potent, selective inhibitor of LIM domain kinase (LIMK) with IC50 of 38 nM for human LIMK1. R-10015 binds to the ATP-binding pocket and acts as a broad-spectrum antiviral compound for HIV infection.

GC65085 3'-Azido-3'-deoxy-5-methylcytidine

GC64590 Dexelvucitabine

GC64261 Censavudine

GC63541 FNC-TP

GC63486 Stampidine

GC49022 Didanosine-d2 An internal standard for the quantification of didanosine

GC62607 EFdA-TP tetraammonium

GC62223 Ro-0335 An NNRTI and active metabolite of elsulfavirine

GC47770 Nevirapine-d4 An internal standard for the quantification of nevirapine

GC46767 Abacavir-d4 An internal standard for the quantification of abacavir

GC61134 Nigranoic acid

GC60358 Tenofovir diphosphate triethylamine

GC60357 Tenofovir diphosphate An HIV reverse transcriptase and HBV polymerase inhibitor

GC45825 Etravirine-d6 An internal standard for the quantification of etravirine

GC37760 Tenofovir Disoproxil A prodrug of the antiviral tenofovir

GC37759 Tenofovir alafenamide hemifumarate Tenofovir alafenamide (TAF, GS-7340) hemifumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection.

GC37758 Tenofovir alafenamide fumarate Tenofovir alafenamide (TAF, GS-7340) fumarate is a prodrug of tenofovir but results in significantly higher intracellular tenofovir concentrations and lower serum levels. Tenofovir alafenamide is a novel nucleotide reverse transcriptase inhibitor for the treatment of HIV-1 infection.